{"id":66077,"name":"VIATRIS (MYLAN, INC)","slug":"viatris-mylan-inc","state":"PA","country":"United States of America","description":"Generics and specialty pharmaceutical company","totalSpending":340000,"filings":7,"yearlySpending":[{"year":2025,"income":340000}],"issues":["HCR","CPT"],"firms":["S-3 GROUP"],"lobbyists":["ASHLEY DAVIS","KRISTI REMINGTON","SHIMON STEIN","MALLOY MCDANIEL","CHRISTOPHER BUKI"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to drug pricing; pharmaceutical supply chain; modernizational of prescribing information for physicians and pharmacists; Increasing Trasnparency in Generic Drug Applications, S.1302 and","Issues related to drug pricing; pharmaceutical supply chain; modernization of prescribing information for physicians and pharmacists; Increasing Transparency in Generic Drug Applications, S.1302 and H","Issues related to drug pricing; pharmaceutical supply chain; modernization of prescribing information for physicians and pharmacists; Increasing Transparency in Generic Drug Applications, S.1302 and H","Issues related to drug pricing; pharmaceutical supply chain; modernization of prescribing information for physicians and pharmacists; Increasing Transparency in Generic Drug Applications, S.1302 and H","Issues related to patent policy and reform, including to address patent thickets and FDA/PTO Coordination; S.527 Prescription Pricing for the People Act; S.1096 Preserve Access to Affordable Generics "],"years":[2025]}